| Record Information |
|---|
| Version | 2.0 |
|---|
| Created at | 2022-05-11 18:54:16 UTC |
|---|
| Updated at | 2022-05-11 18:54:16 UTC |
|---|
| NP-MRD ID | NP0091996 |
|---|
| Secondary Accession Numbers | None |
|---|
| Natural Product Identification |
|---|
| Common Name | Kynuramine |
|---|
| Description | Kynuramine belongs to the class of organic compounds known as alkyl-phenylketones. These are aromatic compounds containing a ketone substituted by one alkyl group, and a phenyl group. An aromatic ketone that is aniline substituted at position 2 by a 3-aminopropanoyl group. Kynuramine was first documented in 1977 (PMID: 562342). Kynuramine is a very strong basic compound (based on its pKa) (PMID: 22547660) (PMID: 3428356) (PMID: 4017223) (PMID: 510362) (PMID: 6115758) (PMID: 6132830). |
|---|
| Structure | InChI=1S/C9H12N2O/c10-6-5-9(12)7-3-1-2-4-8(7)11/h1-4H,5-6,10-11H2 |
|---|
| Synonyms | | Value | Source |
|---|
| Diaminopropiophenone | ChEBI | | 3-Amino-1-(2-aminophenyl)-1-propanone | HMDB | | 2,3 Diaminopropiophenone | HMDB | | 2,3-Diaminopropiophenone | HMDB |
|
|---|
| Chemical Formula | C9H12N2O |
|---|
| Average Mass | 164.2044 Da |
|---|
| Monoisotopic Mass | 164.09496 Da |
|---|
| IUPAC Name | 3-amino-1-(2-aminophenyl)propan-1-one |
|---|
| Traditional Name | 3-amino-1-(2-aminophenyl)propan-1-one |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | NCCC(=O)C1=C(N)C=CC=C1 |
|---|
| InChI Identifier | InChI=1S/C9H12N2O/c10-6-5-9(12)7-3-1-2-4-8(7)11/h1-4H,5-6,10-11H2 |
|---|
| InChI Key | QLPVTIQQFGWSQQ-UHFFFAOYSA-N |
|---|
| Experimental Spectra |
|---|
|
| Not Available | | Predicted Spectra |
|---|
|
| | Spectrum Type | Description | Depositor ID | Depositor Organization | Depositor | Deposition Date | View |
|---|
| 1D NMR | 13C NMR Spectrum (1D, 25 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 252 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 50 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 75 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 101 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 126 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 151 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 176 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 201 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 226 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum |
| | Chemical Shift Submissions |
|---|
|
| Not Available | | Species |
|---|
| Species of Origin | |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as alkyl-phenylketones. These are aromatic compounds containing a ketone substituted by one alkyl group, and a phenyl group. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organic oxygen compounds |
|---|
| Class | Organooxygen compounds |
|---|
| Sub Class | Carbonyl compounds |
|---|
| Direct Parent | Alkyl-phenylketones |
|---|
| Alternative Parents | |
|---|
| Substituents | - Alkyl-phenylketone
- Benzoyl
- Aryl alkyl ketone
- Aniline or substituted anilines
- Monocyclic benzene moiety
- Beta-aminoketone
- Benzenoid
- Vinylogous amide
- Organopnictogen compound
- Amine
- Primary amine
- Organonitrogen compound
- Primary aliphatic amine
- Organic nitrogen compound
- Organic oxide
- Hydrocarbon derivative
- Aromatic homomonocyclic compound
|
|---|
| Molecular Framework | Aromatic homomonocyclic compounds |
|---|
| External Descriptors | |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Predicted Properties | |
|---|
| General References | - Li B, Lv X, Geng L, Qing H, Deng Y: Proteoliposome-based capillary electrophoresis for screening membrane protein inhibitors. J Chromatogr Sci. 2012 Aug;50(7):569-73. doi: 10.1093/chromsci/bms053. Epub 2012 Apr 29. [PubMed:22547660 ]
- Mendelson SD, Lee N, Gorzalka BB: Intraventricular administration of l-kynurenine and kynuramine facilitates lordosis in the female rat. Eur J Pharmacol. 1987 Oct 27;142(3):447-51. doi: 10.1016/0014-2999(87)90086-0. [PubMed:3428356 ]
- Matsumoto T, Suzuki O, Furuta T, Asai M, Kurokawa Y, Nimura Y, Katsumata Y, Takahashi I: A sensitive fluorometric assay for serum monoamine oxidase with kynuramine as substrate. Clin Biochem. 1985 Apr;18(2):126-9. doi: 10.1016/s0009-9120(85)80094-1. [PubMed:4017223 ]
- Dial EJ, Clarke DE: Rat and human cardiac monoamine oxidase: a comparison with other tissues. Eur J Pharmacol. 1979 Oct 1;58(3):313-9. doi: 10.1016/0014-2999(79)90480-1. [PubMed:510362 ]
- Massey JB, Churchich JE: Kynuramine, a fluorescent substrate and probe of plasma amine oxidase. J Biol Chem. 1977 Nov 25;252(22):8081-4. [PubMed:562342 ]
- Johnson TD, Clarke DE: An alpha-adrenoceptor inhibitory action of kynuramine. Eur J Pharmacol. 1981 Jul 10;72(4):351-6. doi: 10.1016/0014-2999(81)90574-4. [PubMed:6115758 ]
- Johnson TD, Clarke DE: Blood pressure and heart rate effects of kynuramine in pithed rats. Eur J Pharmacol. 1983 Feb 18;87(2-3):323-6. doi: 10.1016/0014-2999(83)90346-1. [PubMed:6132830 ]
- Charlton KG, Johnson TD, Hamed AT, Clarke DE: Cardiovascular actions of kynuramine and 5-hydroxykynuramine in pithed rats. J Neural Transm. 1983;57(4):199-211. doi: 10.1007/BF01248993. [PubMed:6140297 ]
- Johnson TD, Charlton KG, Clarke DE: Cardiac norepinephrine releasing action of kynuramine, an endogenous diamine derived from L-tryptophan. Life Sci. 1984 Dec 3;35(23):2303-10. doi: 10.1016/0024-3205(84)90521-6. [PubMed:6503615 ]
- Charlton KG, Johnson TD, Maurice RW, Clarke DE: Kynuramine: high affinity for [3H]tryptamine binding sites. Eur J Pharmacol. 1984 Nov 27;106(3):661-4. doi: 10.1016/0014-2999(84)90076-1. [PubMed:6519183 ]
|
|---|